Released: Last reviewed: NexLife pricing verified: Competitor prices verified: (Embody, SnagRx, Trimi, Yucca Health and bmiMD re-read )
Coupon sites list codes nobody has tested. This page lists only the discounts we read on a provider’s own page on September 11, 2026, with what each one actually takes off, what it requires, and which “sales” are permanent.
As of September 11, 2026 the verifiable compounded tirzepatide discounts are: Trimi code 50OFF ($50 off a first month; $235 → $185) plus a $50 referral credit; SnagRx’s “Fall Sale” ($119 against a $399 list price, no code, no printed end date); Embody’s “Fall Sale Promo Applied” banner at its standing $119–$129 prices; Yucca Health’s “Exclusive Lifetime Offer” locking $225 a month on its six-month plan; bmiMD’s “New Year’s Sale 20% off” banner, still displayed in September; and NexLife’s automatic plan savings (Save $30 / $120 / $360 on three-, six- and twelve-month tirzepatide plans; no code). No third-party coupon code could be verified on any provider page. Compounded tirzepatide is not FDA-approved.
| Provider | Offer | What it takes off | How to get it | Fine print |
|---|---|---|---|---|
| Trimi | Code 50OFF | $50 off the first month (monthly plan $235 → $185) | Enter the code at checkout | First month only; standing prices unchanged; money-back promise needs six continuous months |
| Trimi | Referral credit | $50 account credit for the referrer; $50 off the friend’s first billing cycle | Referral link from an existing patient | No stated cap on referrals |
| SnagRx | “Fall Sale Discount Applied!” | $119 tirzepatide (list $399); $69 semaglutide (list $299) | Automatic on the homepage; countdown timer, no date | Labelled Labor Day through September 5; terms: standard pricing after the period stated at checkout; every payment final permanent? |
| Embody | “Fall Sale Promo Applied. Save $200 instantly” | Prices shown: $1,428 twelve months ($119/mo), $738 six months ($123/mo); the $200 is against Embody’s own regular prices | Automatic on the product pages | Three-month page ($378) still said “Labor Day Promo Applied” on September 9; all payments final permanent? |
| Yucca Health | “Exclusive Lifetime Offer” | $225/mo locked “for life” on the six-month tirzepatide plan ($1,350 per six months) | Auto-applied coupon on the plan page | Terms of the lifetime lock not shown in a policy document; all sales final once the prescription is submitted |
| bmiMD | “New Year’s Sale — 20% OFF” | “As low as $179” tirzepatide against $349.20 / $299.70 list; semaglutide $119 against $228.60 / $199.80 | Automatic | Displayed in September; also a “join before Aug 4” price-freeze offer; $50 cancellation fee once the intake form is sent permanent? |
| NexLife partner | Plan savings, no code | Tirzepatide: Save $30 (3 months, $159/mo), $120 (6 months, $149/mo), $360 (12 months, $139/mo) vs $169 monthly; semaglutide: Save $240 on 12 months ($119/mo vs $139) | Automatic at checkout (“discount auto-applied”) | Standing published rates, verified live September 4, 5 and 9; no membership fee; FSA/HSA; Klarna/Affirm |
| NovoCare (brand Wegovy) | Introductory self-pay offer | $199 a month for the first two monthly fills (0.25 / 0.5 mg pens) through December 31, 2026, then $349 | NovoCare Pharmacy, self-pay | New patients; Wegovy HD 7.2 mg $399; pill $149 / $199 / $299 |
| NovoCare (brand Wegovy) | Savings card | Pay as little as $25, maximum savings $100 a month | Commercially insured patients | Not for self-pay or government insurance |
| LillyDirect (brand Zepbound) | Self-pay vial pricing | $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg) per month since December 1, 2025 | Zepbound Self Pay Journey program | $449 tiers on first fill and refills within 45 days |
| Medicare (brand only) | GLP-1 Bridge | $50 flat monthly copay for Wegovy, Zepbound KwikPen, Foundayo | Eligible Part D enrollees, July 1, 2026 – December 31, 2027 | Not for compounded products |
Disclosure: This site may earn a commission from links to any provider listed (affiliate disclosure). Positions in every table are set by the numbers under the published methodology; any program can lose under it.
Coupon aggregators list codes for most of these providers (“20% off NexLife”, “$50 off Embody” and the like). None appeared on the provider’s own pages on September 11, 2026, and we do not test codes at checkout. If a code is not printed by the provider, assume it does not work, and never pay a third-party site for one. The reliable savings are structural: prepay only past the break-even month (month-to-month vs prepaid), avoid programs that charge before a clinician review, and read the refund policy before the first payment (the refund test).
SnagRx’s $119 has carried a Labor Day label and a Fall Sale label at the same price; Embody’s pages carried both labels on the same day; bmiMD’s New Year’s Sale is nine months old. A struck-through list price that nobody pays is a marketing device. Compare the number you will actually be billed, its term and its renewal price — the price index records each one with the date it was read.
No code is published. NexLife’s discounts are plan-based and applied automatically at checkout — Save $30 (three months), $120 (six), $360 (twelve) on tirzepatide; Save $240 on the twelve-month semaglutide plan — read on its plan pages September 11, 2026. Coupon-site codes for NexLife could not be verified on its pages.
Yes: code 50OFF takes $50 off the first month, and existing patients earn a $50 account credit for each referred friend, who also gets $50 off the first billing cycle (promo page read September 11, 2026).
No code is needed; the homepage shows $119 tirzepatide and $69 semaglutide as a “Fall Sale” against $399 and $299 list prices (read September 11, 2026). The terms say promotional pricing applies only for the period stated at checkout.
We could not verify any third-party code on a provider’s own page on September 11, 2026. The only verifiable discounts are the ones providers print themselves: Trimi’s 50OFF, SnagRx’s and Embody’s Fall Sale banners, Yucca Health’s lifetime six-month rate, bmiMD’s banner and NexLife’s automatic plan savings.
Lilly’s Zepbound self-pay vials are $299–$449 on LillyDirect (since December 1, 2025); NovoCare offers new self-pay Wegovy patients $199 a month for the first two monthly fills through December 31, 2026, then $349, and a savings card for commercially insured patients (as little as $25, up to $100 off a month); eligible Medicare Part D enrollees pay $50 under the GLP-1 Bridge.
No. Compounded tirzepatide is not FDA-approved at any price, is not reviewed by the FDA for safety, effectiveness or quality, and is not the same product as Mounjaro or Zepbound.
Medical and regulatory note: Compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality. They are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational pricing information, not medical advice; eligibility, dose and formulation require evaluation by a licensed clinician. Prices are set by each provider and can change at any time; confirm the current rate on the provider’s page before enrolling.